Belpointe Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $202K | Hold |
1,252
| – | – | 0.01% | 885 |
|
2025
Q1 | $213K | Sell |
1,252
-1,101
| -47% | -$187K | 0.01% | 843 |
|
2024
Q4 | $401K | Hold |
2,353
| – | – | 0.02% | 569 |
|
2024
Q3 | $405K | Buy |
+2,353
| New | +$405K | 0.02% | 557 |
|
2024
Q2 | – | Sell |
-3,298
| Closed | -$507K | – | 877 |
|
2024
Q1 | $507K | Buy |
3,298
+1,409
| +75% | +$217K | 0.04% | 432 |
|
2023
Q4 | $299K | Buy |
1,889
+418
| +28% | +$66.1K | 0.03% | 520 |
|
2023
Q3 | $215K | Buy |
+1,471
| New | +$215K | 0.02% | 578 |
|
2023
Q2 | – | Sell |
-8,050
| Closed | -$1.25M | – | 1469 |
|
2023
Q1 | $1.25M | Sell |
8,050
-494
| -6% | -$76.6K | 0.07% | 286 |
|
2022
Q4 | $1.32M | Buy |
8,544
+3,539
| +71% | +$545K | 0.08% | 255 |
|
2022
Q3 | $661K | Buy |
+5,005
| New | +$661K | 0.04% | 409 |
|
2017
Q4 | – | Sell |
-3,858
| Closed | -$395K | – | 472 |
|
2017
Q3 | $395K | Buy |
+3,858
| New | +$395K | 0.09% | 254 |
|